 Fenofibrate
"Fenofibrate" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An antilipemic agent which reduces both CHOLESTEROL and TRIGLYCERIDES in the blood.
| Descriptor ID |
D011345
|
| MeSH Number(s) |
D02.241.081.114.968.500.625 D02.355.726.305.625 D02.455.426.559.389.115.124.750 D02.455.426.559.389.657.654.305.625 D02.522.223.750
|
| Concept/Terms |
Fenofibrate- Fenofibrate
- Procetofene
- Phenofibrate
- Procetofen
Tricor- Tricor
- Normalip
- Abbott Brand of Procetofen
Apo-Feno-Micro- Apo-Feno-Micro
- Apo Feno Micro
- Apotex Brand of Procetofen
- Apo-Fenofibrate
- Apo Fenofibrate
CiL- CiL
- Lichtenstein Brand of Procetofen
Fénofibrate MSD- Fénofibrate MSD
- GNR-Pharma Brand of Procetofen
- GNR Pharma Brand of Procetofen
Liparison- Liparison
- Novartis Brand of Procetofen
Lipanthyl- Lipanthyl
- Fournier Brand of Procetofen
- Fénofibrate Debat
- Debat, Fénofibrate
- Lipantil
- United Drug Brand of Procetofen
- Lipidil-Ter
- Lipidil Ter
- Schering-Plough Brand of Procetofen
- Schering Plough Brand of Procetofen
- Secalip
- Supralip
- Fenofibrat FPh
- Lipidil
durafenat- durafenat
- Merck dura Brand of Procetofen
Fenobeta- Fenobeta
- betapharm Brand of Procetofen
Nu-Fenofibrate- Nu-Fenofibrate
- Nu Fenofibrate
- Nu-Pharm Brand of Procetofen
- Nu Pharm Brand of Procetofen
Livesan- Livesan
- Bouchara Brand of Procetofen
Lofibra- Lofibra
- Gate Brand of Procetofen
Fenofanton- Fenofanton
- Q-Pharm Brand of Procetofen
- Q Pharm Brand of Procetofen
- Anto Brand of Procetofen
Fenofibrat AZU- Fenofibrat AZU
- AZU, Fenofibrat
- Azupharma Brand of Procetofen
fenofibrat von ct- fenofibrat von ct
- ct-Arzneimittel Brand of Procetofen
- ct Arzneimittel Brand of Procetofen
Antara Micronized Procetofen- Antara Micronized Procetofen
- Micronized Procetofen, Antara
- Procetofen, Antara Micronized
- Reliant Brand of Procetofen
- Procetofen Reliant Brand
|
Below are MeSH descriptors whose meaning is more general than "Fenofibrate".
Below are MeSH descriptors whose meaning is more specific than "Fenofibrate".
This graph shows the total number of publications written about "Fenofibrate" by people in UAMS Profiles by year, and whether "Fenofibrate" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2016 | 1 | 0 | 1 | | 2015 | 2 | 0 | 2 | | 2012 | 2 | 0 | 2 | | 2009 | 0 | 1 | 1 | | 2007 | 4 | 0 | 4 | | 2006 | 1 | 0 | 1 | | 2004 | 0 | 1 | 1 | | 2001 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Fenofibrate" by people in Profiles over the past ten years.
-
Croyal M, Kaabia Z, Le?n L, Ramin-Mangata S, Baty T, Fall F, Billon-Crossouard S, Aguesse A, Hollstein T, Sullivan DR, Nobecourt E, Lambert G, Krempf M. Fenofibrate decreases plasma ceramide in type 2 diabetes patients: A novel marker of CVD? Diabetes Metab. 2018 Mar; 44(2):143-149.
-
Farris RA, Price ET. Reverse Translational Study of Fenofibrate's Observed Effects in Diabetes-Associated Retinopathy. Clin Transl Sci. 2017 03; 10(2):110-116.
-
Esmaeili MA, Yadav S, Gupta RK, Waggoner GR, Deloach A, Calingasan NY, Beal MF, Kiaei M. Preferential PPAR-a activation reduces neuroinflammation, and blocks neurodegeneration in vivo. Hum Mol Genet. 2016 Jan 15; 25(2):317-27.
-
Stolarz AJ, Farris RA, Wiley CA, O'Brien CE, Price ET. Fenofibrate Attenuates Neutrophilic Inflammation in Airway Epithelia: Potential Drug Repurposing for Cystic Fibrosis. Clin Transl Sci. 2015 Dec; 8(6):696-701.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|